Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.

How to buy Cronos Group stock | 6.07

Own Cronos Group stock in just a few minutes.


Fact checked

Cronos Group Inc is a drug manufacturers—specialty & generic business based in the US. Cronos Group shares (CRON) are listed on the NASDAQ and all prices are listed in US Dollars. Cronos Group employs 631 staff and has a trailing 12-month revenue of around USD$31.4 million.

How to buy shares in Cronos Group

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Cronos Group. Find the stock by name or ticker symbol: CRON. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Cronos Group reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$6.07, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Cronos Group, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Cronos Group. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Cronos Group's share price?

Since the stock market crash in March caused by coronavirus, Cronos Group's share price has had significant negative movement.

Its last market close was USD$6.07, which is 15.10% down on its pre-crash value of USD$7.15 and 51.75% up on the lowest point reached during the March crash when the shares fell as low as USD$4.

If you had bought USD$1,000 worth of Cronos Group shares at the start of February 2020, those shares would have been worth USD$718.08 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$851.32.

Cronos Group share price

Use our graph to track the performance of CRON stocks over time.

Cronos Group shares at a glance

Information last updated 2020-10-20.
Latest market closeUSD$6.07
52-week rangeUSD$4.43 - USD$9.19
50-day moving average USD$5.3386
200-day moving average USD$5.9419
Wall St. target priceN/A
PE ratio 2.6143
Dividend yield N/A (0%)
Earnings per share (TTM) USD$1.952

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Stocks, Mutual funds, ETFs, Forex
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Futures
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cronos Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cronos Group price performance over time

Historical closes compared with the close of $6.07 from 2020-10-22

1 week (2020-10-22) 6.07
1 month (2020-09-29) 20.20%
3 months (2020-07-29) -10.07%
6 months (2020-04-29) -2.57%
1 year (2019-10-29) -27.48%
2 years (2018-10-29) -10.74%
3 years (2017-10-27) 147.73%
5 years (2015-10-25) N/A

Is Cronos Group under- or over-valued?

Valuing Cronos Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cronos Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Cronos Group's P/E ratio

Cronos Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3x. In other words, Cronos Group shares trade at around 3x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Cronos Group financials

Revenue TTM USD$31.4 million
Gross profit TTM USD$-15,964,000
Return on assets TTM -5.46%
Return on equity TTM 48.76%
Profit margin 2023.3%
Book value $4.759
Market capitalisation USD$2 billion

TTM: trailing 12 months

Shorting Cronos Group shares

There are currently 48.9 million Cronos Group shares held short by investors – that's known as Cronos Group's "short interest". This figure is 1.2% down from 49.5 million last month.

There are a few different ways that this level of interest in shorting Cronos Group shares can be evaluated.

Cronos Group's "short interest ratio" (SIR)

Cronos Group's "short interest ratio" (SIR) is the quantity of Cronos Group shares currently shorted divided by the average quantity of Cronos Group shares traded daily (recently around 2.6 million). Cronos Group's SIR currently stands at 19.17. In other words for every 100,000 Cronos Group shares traded daily on the market, roughly 19170 shares are currently held short.

However Cronos Group's short interest can also be evaluated against the total number of Cronos Group shares, or, against the total number of tradable Cronos Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cronos Group's short interest could be expressed as 0.14% of the outstanding shares (for every 100,000 Cronos Group shares in existence, roughly 140 shares are currently held short) or 0.2707% of the tradable shares (for every 100,000 tradable Cronos Group shares, roughly 271 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Cronos Group.

Find out more about how you can short Cronos Group stock.

Cronos Group share dividends

We're not expecting Cronos Group to pay a dividend over the next 12 months.

Cronos Group share price volatility

Over the last 12 months, Cronos Group's shares have ranged in value from as little as $4.43 up to $9.19. A popular way to gauge a stock's volatility is its "beta".

CRON.US volatility(beta: 1.75)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cronos Group's is 1.7539. This would suggest that Cronos Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Cronos Group overview

Cronos Group Inc. operates as a cannabinoid company in the United States and internationally. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through ecommerce, retail, and hospitality partner channels. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. Its brand portfolio includes PEACE NATURALS, a global wellness platform; adult-use brands comprise COVE and Spinach; and hemp-derived CBD brands consists of Lord Jones and PEACE+. Cronos Group Inc. is based in Toronto, Canada.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site